[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"home-based-chemotherapy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:home-based-chemotherapy":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":29,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":4},"100654732","home-based-intravenous-cytarabine-treatment-for-acute-myeloid-leukemia-a-national-danish-study-of-feasibility-costs-and-implementation-100654732",false,"NCT07802015","Home-based Intravenous Cytarabine Treatment for Acute Myeloid Leukemia: a National Danish Study of Feasibility, Costs, and Implementation","Home-CALM Home-based Treatment With Intravenous Cytarabine for Acute Myeloid Leukemia: Feasibility, Health Economics, Barriers and Facilitators - a National Multicenter Study in Denmark","HOME-CALM","Inclusion Criteria:\n\nPATIENT (Study 2+3)\n\n* Age ≥ 18 years\n* Can provide informed consent.\n* Participants that have been diagnosed with AML, to receive IV-Cytarabine\n\nCAREGIVER (Study 2+3)\n\n* Age ≥18 years\n* Can provide informed consent.\n\nHEALTHCARE PROFESSIONALS (Study 3)\n\n* Employed as Physician or Registered Nurse\n* Work experience with home-based treatment for patients with AML for minimum 1 year.\n\nExclusion Criteria (Patient\u002FCaregiver):\n\n* Inability to read, write and\u002For speak Danish or English\n* Otherwise deemed unethical to participate due to mental disability","ALL","18 Years",{"count":20,"type":21},80,"ESTIMATED","OBSERVATIONAL","The goal of this observational multicenter feasibility and implementation study is to evaluate home-based treatment with intravenous Cytarabine for patients with acute myeloid leukemia in Denmark. The study aims to generate research-based evidence on feasibility, safety, patient impact, health economic costs, and implementation of home-based intravenous chemotherapy treatment.\n\nThe main questions it aims to answer are:\n\n1\\. What is the existing evidence on home-based chemotherapy treatment for patients with hematological malignancies, including feasibility, safety, symptoms, quality of life, and cost-effectiveness?\n\n2\\. Is home-based treatment with intravenous Cytarabine feasible and safe for patients with acute myeloid leukemia in Denmark?\n\n3\\. What are the costs, patient-reported outcomes, and caregiver roles related to home-based Cytarabine treatment?\n\n4\\. What are the key barriers and facilitators experienced by patients, caregivers, and healthcare professionals during home-based Cytarabine treatment? Which national strategies and recommendations can support the implementation, scalability, sustainability, and equitable access to home-based intravenous Cytarabine treatment across healthcare settings in Denmark?",[25,26,27,28],"Hematologic Cancer","Acute Myeloid Leukaemia (AML)","Hospital At Home","Home-based Chemotherapy",[30,31,32,33],"Implementation Science","Cost Analysis","Feasibility Studies","Safety and effectiveness","NOT_YET_RECRUITING","2026-09-02",{"date":37,"type":38},"2026-09-03","ACTUAL",{"date":40,"type":21},"2026-08-17",{"date":42,"type":21},"2029-01-30",{"name":44,"class":45},"Zealand University Hospital","OTHER"]